Patents by Inventor Lucie MANACHE-ALBERICI

Lucie MANACHE-ALBERICI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating multiple myeloma
    Patent number: 11939390
    Abstract: The present disclosure provides methods for treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in an individual who received at least two prior therapies for multiple myeloma. The methods comprise administering to the individual an anti-CD38 antibody, pomalidomide, and dexamethasone. Also provided are methods of improving renal impairment in an individual having multiple myeloma.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: March 26, 2024
    Assignee: Sanofi-Aventis U.S. LLC
    Inventors: Heloise Audat, Audrey Bonestebe, Frank Campana Zambrano, Sylvain Huille, Solenn Le-Guennec, Lucie Manache-Alberici
  • CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION
    Publication number: 20220202946
    Abstract: Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 30, 2022
    Inventors: Jean-René AUTHELIN, Fethi BENSAID, Audrey BONESTEBE, Sylvain HUILLE, Marie LEMAN, Lucie MANACHE-ALBERICI
  • METHODS OF TREATING MULTIPLE MYELOMA
    Publication number: 20200239589
    Abstract: The present disclosure provides methods for treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in an individual who received at least two prior therapies for multiple myeloma. The methods comprise administering to the individual an anti-CD38 antibody, pomalidomide, and dexamethasone. Also provided are methods of improving renal impairment in an individual having multiple myeloma.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Inventors: Heloise AUDAT, Audrey BONESTEBE, Frank CAMPANA ZAMBRANO, Sylvain HUILLE, Solenn LE-GUENNEC, Lucie MANACHE-ALBERICI